3 questions about sourcing & safety.
Look for four things: a third-party COA from an independent lab (not their own testing — an actual lab with a name you can Google and a website that loads), a real company behind the storefront (registered business, actual address, humans who answer email), lyophilized powder in a sealed vial (not pre-mixed liquid that's been sitting warm through customs), and cold chain shipping (insulated packaging with gel packs, not a padded envelope and a prayer). The batch number on your COA should match the batch number on your vial. If it doesn't, the COA is decoration. Janoshik Analytical assigns verifiable keys to every report — if your supplier publishes Janoshik results you can check at janoshik.com/verify, that's a green flag. Take the vialprep supplier quiz and download the full checklist before your first order. One red flag = pause. Two = walk.
The honest answer: it depends on which peptide and how you're getting it. A few peptides are fully FDA-approved with a prescription — semaglutide, tirzepatide, PT-141 (bremelanotide). Those are straightforward. Everything else exists in a grey zone. Research peptides are legal to buy "for research purposes." They're not approved for human use. Everyone buying them knows they're not setting up a lab in their apartment. That's the reality. Nobody's getting arrested for buying BPC-157, but you also don't have regulatory protections if the product is bunk. The RFK reclassification in February 2026 moved many popular peptides back to Category 1, meaning compounding pharmacies can legally prepare them with a prescription again — so the prescription route is increasingly viable if you want to stay fully above board.
Most GPs genuinely don't know what peptides are beyond insulin and semaglutide. You might spend more time explaining what BPC-157 is than discussing whether you should be running it. That's not judgment — it's just not in their training. Functional medicine and integrative docs are a different story — many of them prescribe peptides and will actually have an informed conversation with you. If you want a supportive medical partner for this, look for practitioners who specifically mention peptide therapy. You don't have to tell your GP everything, but you should tell someone on your medical team. If you're doing bloodwork, mention what you're running — it affects interpretation. And if something goes sideways, the ER doctor needs to know what you've been taking. This isn't about permission. It's about having a safety net.
← All FAQ topics | Browse all peptides
vialprep research · Sources: PubMed, FDA, peer-reviewed trials · How we verify